Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms (NCT06484400) | Clinical Trial Compass
CompletedNot Applicable
Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms
Turkey (Türkiye)45 participantsStarted 2024-09-04
Plain-language summary
Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study.
Principal Investigator: Dr. Metin Çınaroğlu, Istanbul Nişantaşı University, Department of Psychology.
Study Duration: October, 2023 - Ongoing.
Objective: The study aims to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Ericksonian Hypnotherapy in alleviating symptoms of depression and anxiety among volunteers in Istanbul.
Methods: This randomized controlled trial will enroll healthy individuals aged 18-65 who exhibit symptoms of depression and anxiety but are not clinically diagnosed. Participants will be randomly divided into three groups: one receiving CBT, another receiving Ericksonian Hypnotherapy, and a control group receiving no therapeutic intervention. Standard psychological assessment tools such as the Beck Depression Inventory and Beck Anxiety Inventory will be used to measure outcomes.
Significance: Depression and anxiety are prevalent psychological disorders that significantly impair quality of life. Comparing these two therapeutic approaches may provide valuable insights into more effective psychological treatment strategies, thereby enhancing patient care in mental health settings.
Study Protocol:
Recruitment: 150 volunteers will be screened using socio-demographic forms and psychological assessments.
Intervention: Participants will undergo CBT or Ericksonian Hypnotherapy according to their group allocation, while the control group will be observed without intervention.
Evaluation: Pre- and post-treatment assessments will gauge the therapy's impact on depression and anxiety symptoms.
Expected Outcome: The study expects to demonstrate the relative efficacy of CBT and Ericksonian Hypnotherapy, providing evidence to guide treatment choices for managing depression and anxiety symptoms.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age: Participants must be between 18 and 65 years old.
* Symptoms: Participants must display symptoms of depression and/or anxiety, but not necessarily have a clinical diagnosis.
* Voluntary Participation: Participants must voluntarily agree to participate and must be able to provide informed consent.
* Residency: Participants must reside in or near the study location (Istanbul) to attend in-person sessions.
* Language: Participants must be proficient in the language in which the therapy is delivered (presumably Turkish).
* Availability: Participants must be available to attend all scheduled sessions over the course of the study (12 weekly sessions).
Exclusion Criteria:
* Psychiatric Diagnosis: Individuals with a severe psychiatric disorder requiring immediate or intensive intervention (e.g., schizophrenia, bipolar disorder, or severe depression with suicidal ideation).
* Current Psychotherapy: Individuals currently receiving other forms of psychotherapy or psychological treatment.
* Substance Abuse: Individuals with active substance abuse issues or dependencies that could interfere with therapy.
* Cognitive Impairments: Individuals with cognitive impairments or neurological disorders that would limit their ability to participate fully in therapy.
* Medical Conditions: Individuals with severe medical conditions that could interfere with participation in the study or pose a risk during the therapy sessions.
* Language Barrier: Non-Turkish speakers or t…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared CBT and Ericksonian hypnosis therapy for depression and anxiety — based on what you know about the results, did either approach show a meaningful difference in BDI or BAI scores, and which might be a better fit for my specific situation?
2Since this trial is already completed, does that mean findings are available that could inform my treatment plan today, or are we still waiting on published results?
3I've heard of CBT but not Ericksonian hypnosis therapy — can you explain how hypnosis-based therapy actually works for depression and anxiety, and whether it's something you'd consider recommending alongside or instead of more standard treatments?
4This study was listed as Phase NA, which I understand means it was comparing existing therapies rather than testing a new drug — does that change how confident we can be in applying the findings to my care?
5Before looking at trial-based approaches like these, should I consider whether a standard first-line treatment for my depression or anxiety symptoms makes more sense to try first?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Beck Depression Inventory (BDI) Scores
Timeframe: Baseline and 12 weeks post-intervention
2
Change in Beck Anxiety Inventory (BAI) Scores
Timeframe: Baseline and 12 weeks post-intervention